跳至主要内容
临床试验/EUCTR2010-021396-81-PT
EUCTR2010-021396-81-PT进行中(未招募)1 期

European Low and Intermediate Risk Neuroblastoma Study (a SIOPEN study) - LINES

Instituto de Investigación Sanitaria La Fe de Valencia0 个研究点目标入组 520 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
520

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • DIFFERENT FOR EACH OF THE 10 STUDY GROUPS, DEPENDING ON THE AGE OF THE PATIENT, THE INRG STAGE, BIOLOGICAL CHARACTERISTICS OF THE TUMOR AND THE PRESENCE OF LIFE THREATENING SYMPTOMS, PLEASE CONSULT PROTOCOL.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 520
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • OVERALL EXCLUSION CRITERIA: DIAGNOSIS OF GANGLIONEUROMA OR GANGLIONEUROBLASTOMA INTERMIXED.
  • THE REMAINDER OF THE EXCLUSION CRITERIA ARE DIFFERENT FOR EACH OF THE 10 STUDY GROUPS, DEPENDING ON THE AGE OF THE PATIENT, THE INRG STAGE, BIOLOGICAL CHARACTERISTICS OF THE TUMOR AND THE PRESENCE OF LIFE THREATENING SYMPTOMS, PLEASE CONSULT PROTOCOL.

研究者

发起方
Instituto de Investigación Sanitaria La Fe de Valencia

相似试验